BioMarin Pharmaceutical Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Millions BRL. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 9, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	57,650	77,478	88,130	101,680	90,376	82,667
Market Cap Growth	-17.35%	-12.09%	-13.33%	12.51%	9.32%	35.42%
Enterprise Value	53,115	75,451	87,982	100,715	90,422	82,662
Last Close Price	149.86	203.70	237.12	272.94	257.25	226.00
PE Ratio	20.79	29.35	108.34	135.87	-	18.64
PS Ratio	3.50	4.39	7.51	9.18	8.79	8.56
PB Ratio	1.79	2.21	3.67	4.18	3.80	3.88
P/TBV Ratio	1.92	2.44	4.10	4.73	4.41	4.56
P/FCF Ratio	13.00	25.70	290.28	350.06	77.63	-
P/OCF Ratio	11.84	21.87	114.04	109.34	53.26	186.47
EV/Sales Ratio	3.31	4.28	7.50	9.09	8.79	8.56
EV/EBITDA Ratio	12.66	18.30	62.49	121.62	481.22	1186.81
EV/EBIT Ratio	14.39	21.40	97.60	348.42	-	-
EV/FCF Ratio	11.98	25.03	289.80	346.74	77.67	-
Debt / Equity Ratio	0.10	0.11	0.23	0.24	0.26	0.28
Debt / EBITDA Ratio	0.75	0.93	3.73	6.58	23.56	43.10
Debt / FCF Ratio	0.73	1.30	18.12	20.38	5.38	-
Asset Turnover	0.43	0.41	0.37	0.34	0.31	0.35
Inventory Turnover	0.45	0.50	0.53	0.60	1.49	1.67
Quick Ratio	2.84	2.96	1.45	2.98	2.54	3.07
Current Ratio	4.83	5.33	2.51	4.67	4.16	4.76
Return on Equity (ROE)	9.07%	8.05%	3.51%	3.19%	-1.53%	23.63%
Return on Assets (ROA)	6.15%	5.15%	1.76%	0.55%	-0.78%	-1.09%
Return on Invested Capital (ROIC)	10.50%	8.84%	3.50%	1.18%	-1.74%	-2.46%
Return on Capital Employed (ROCE)	10.40%	8.90%	3.30%	0.90%	-1.40%	-1.70%
Earnings Yield	4.81%	3.41%	0.92%	0.74%	-0.40%	5.37%
FCF Yield	7.69%	3.89%	0.34%	0.29%	1.29%	-0.18%
Buyback Yield / Dilution	-2.10%	-2.67%	-1.39%	-3.34%	4.61%	-7.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.